Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients.

Rosanne OttevangerSylvia van BeugenJuliette M KerstenAndrea W M EversMaarten H Vermeer Rein WillemzeKoen D Quint

Published in: Cancers (2024)

Despite that the newly diagnosed MF patients anticipate a positive treatment effect, few improvements in QoL and symptom reduction were found. These data can be used for adequate expectation management and provide a rationale for further evaluation of treatment regimens in these patients.

Keyphrases

newly diagnosed
end stage renal disease
chronic kidney disease
ejection fraction
prognostic factors
patient reported outcomes
combination therapy
smoking cessation